Autoimmunity and kidney diseases
21 – 30 of 154
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Data-driven subclassification of ANCA-associated vasculitis : model-based clustering of a federated international cohort
(
- Contribution to journal › Article
-
Mark
Drug exposure and subsequent diagnosis with ANCA-associated vasculitis – A population-based case- control study
2024) p.191-191(
- Contribution to conference › Abstract
-
Mark
Assisted peritoneal dialysis compared to in-centre hemodialysis – an observational study of outcomes from the Swedish Renal Registry
(
- Contribution to journal › Article
-
Mark
Long-term outcome of kidney function in patients with ANCA-associated vasculitis
(
- Contribution to journal › Article
-
Mark
Incidence and outcomes of kidney replacement therapy for end-stage kidney disease due to primary glomerular disease in Europe : findings from the ERA Registry
(
- Contribution to journal › Article
-
Mark
International comparison and time trends of first kidne transplant recipient characteristics across Europe : an ERA Registry study
(
- Contribution to journal › Article
-
Mark
Changes in the epidemiology of kidney replacement therapy across Europe in 2020 - The first year of the COVID-19 pandemic : An ERA Registry study
(
- Contribution to journal › Article
- 2023
-
Mark
Prompt Thrombo-Inflammatory Response to Ischemia-Reperfusion Injury and Kidney Transplant Outcomes
(
- Contribution to journal › Article
-
Mark
Management of antineutrophil cytoplasmic antibody–associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 guidelines/recommendations
(
- Contribution to journal › Scientific review
-
Mark
Results of the first nationwide cohort study of outcomes in dialysis and kidney transplant patients before and after vaccination for COVID-19
(
- Contribution to journal › Article